Pediatric Acute Gastrointestinal Bleeding Registry

NCT03090945 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-09-16

No results posted yet for this study

Summary

The goal of this study is to identify significant clinical and laboratory risk factors in pediatric patients with significant upper gastrointestinal bleeding. This is defined as bleeding that necessitates an upper endoscopic evaluation to either diagnose or treat upper GI bleeding during their hospital admission. If a predictive/risk stratification relationship exists, these data could permit a more effective triaging and intervention scheme in pediatric patients presenting with complaints of gastrointestinal bleeding. In addition we want to get a better understanding of the re-bleeding rate after endoscopic therapy for upper GI bleeding and if there are any identifiable risk factors for re-bleeding. Lastly we want to understand best practice management for upper GI bleeding.

Conditions

  • Upper Gastrointestinal Bleeding
  • Gastro Intestinal Bleeding

Interventions

OTHER

This is an obsevational cohort study

no intervention

Sponsors & Collaborators

  • Baylor College of Medicine

    collaborator OTHER
  • Children's Medical Center Dallas

    collaborator OTHER
  • University of Massachusetts, Worcester

    collaborator OTHER
  • Children's Hospital of Philadelphia

    collaborator OTHER
  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER
  • Boston Children's Hospital

    lead OTHER

Principal Investigators

  • Michael A Manfredi, MD · Boston Children's Hospital

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2023-03-01
Completion
2023-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03090945 on ClinicalTrials.gov